Results 1 to 10 of about 31,797 (187)

Etanercept in erythema nodosum leprosum [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: One of the biggest challenges in treating leprosy is the control of reaction events. Patients with lepromatous leprosy may present reaction type II, or erythema nodosum leprosum, during treatment, and this reaction can remain in a recurrent form after ...
Julia Rocha Silva Santos   +3 more
doaj   +6 more sources

Localised erythema nodosum leprosum—A rare entity managed with thalidomide [PDF]

open access: yesSkin Health and Disease
Leprosy is caused by Mycobacterium leprae. The condition primarily affects the skin and peripheral nerves. There are two types of leprosy reactions, Type 1 and Type 2 or erythema nodosum leprosum (ENL).
Chandni Patel   +2 more
doaj   +3 more sources

Management of erythema nodosum leprosum by mycophenolate mofetil

open access: yesIndian Journal of Dermatology, 2008
Mycophenolate mofetil has been tried in 20 cases of chronic relapsing erythema nodosum leprosum reaction where long use of systemic steroid produce complications or are contraindicated.
Banerjee Kalyan, Banerjee Raghubir
doaj   +4 more sources

Beneficial Effect of Minocycline as Additional Treatment to Prednisone for Pustular Erythema Nodosum Leprosum [PDF]

open access: yesInternational Medical Case Reports Journal, 2022
Hendra Gunawan, Yogi Faldian, Reti Hindritiani Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, West Java, IndonesiaCorrespondence: Hendra Gunawan, Department of Dermatology ...
Yogi Faldian   +2 more
exaly   +4 more sources

Necrotic erythema nodosum leprosum – A case of severe lepromatous reaction in a multibacillary leprosy patient [PDF]

open access: yesIDCases
Necrotic erythema nodosum leprosum (ENL) is an uncommon and severe complication of multibacillary leprosy, characterized by intense systemic inflammation, ulcerative lesions, and significant morbidity.
Hrithik Dakssesh Putta Nagarajan   +9 more
doaj   +3 more sources

Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2022
Erythema nodosum leprosum is a severe immune reaction that complicates the usual course of multibacillary leprosy. There is increased activation of T-cells in erythema nodosum leprosum.
Sunil Kumar Gupta, Sushantika Kumari
doaj   +2 more sources

Erythema nodosum leprosum: A rare cause of testicular nodules [PDF]

open access: yesIDCases, 2023
Erythema nodosum leprosum (ENL), characterized by erythematous subcutaneous nodules with multiorgan involvement and systemic manifestations such as neuritis, arthritis, and orchitis, affects approximately 50 % of patients with lepromatous leprosy (LL ...
Adriana Figueroa-Diaz   +2 more
doaj   +2 more sources

Bullous Erythema Nodosum Leprosum [PDF]

open access: yesMedical Journal Armed Forces India, 2013
Leprosy is a chronic, slowly progressive, granulomatous infection caused by Mycobacterium leprae. Reactions in leprosy, also known as lepra reaction, are not uncommon. They are of two types – Type 1 lepra reaction (occurring in borderline disease) and the Type 2 lepra reaction (occurring in lepromatous disease).1 Skin lesions in lepra reaction ...
Deepak Vashisht, A L Das
exaly   +3 more sources

Ocular erythema nodosum leprosum: An immunohistochemical study [PDF]

open access: yesIndian Journal of Ophthalmology, 2020
Episcleritis, scleritis, and anterior uveitis are common clinical manifestations of ocular leprosy. Erythema nodosum leprosum (ENL) is an acute, exaggerated systemic immunological reaction that complicates the course of this chronic indolent disease.
S R Rathinam   +2 more
doaj   +2 more sources

Erythema Nodosum Leprosum. [PDF]

open access: yesJ Gen Intern Med, 2021
Woldemichael B, Molla M, Aronowitz P.
europepmc   +4 more sources

Home - About - Disclaimer - Privacy